Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease

Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease

Abstract Background SLE manifestations after ESRD may be underdiagnosed and undertreated, contributing to increased morbidity and mortality. Whether specific symptoms persist after ESRD or a shift towards new manifestations occurs has not been extensively studied, especially in the non-Caucasian pat...

Full description

Bibliographic Details
Main Authors: Maria Salgado Guerrero, Alejandra Londono Jimenez, Chrisanna Dobrowolski, Wenzhu B. Mowrey, Beatrice Goilav, Shudan Wang, Anna Broder
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Nephrology
Subjects:
Disease activity
Systemic lupus Erythematosus
End-stage renal disease
Hydroxychloroquine
Online Access:http://link.springer.com/article/10.1186/s12882-020-02083-2

Internet

http://link.springer.com/article/10.1186/s12882-020-02083-2

Similar Items